Cascade Investment Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Cascade Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$700.03 - $830.35 $11,200 - $13,285	16 Added 0.71%	2,275 $1.63 Million
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $30,622 - $37,213	-45 Reduced 1.95%	2,259 $1.86 Million
Q4 2022 Jan 26, 2023	SELL	$705.89 - $766.39 $61,412 - $66,675	-87 Reduced 3.64%	2,304 $0
Q3 2022 Nov 15, 2022	SELL	$573.97 - $724.32 $253,120 - $319,425	-441 Reduced 15.57%	2,391 $1.79 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $2,741 - $3,694	5 Added 0.18%	2,832 $1.67 Billion
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $424,457 - $524,027	781 Added 38.17%	2,827 $1.79 Million
Q2 2021 Aug 04, 2021	BUY	$472.8 - $558.54 $967,348 - $1.14 Million	2,046 New	2,046 $1.14 Million

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.